MARGENZA (margetuximab-cmkb)

**Product type:** Human Prescription Drug

**Active ingredient:** MARGETUXIMAB

**Strength:** 25 mg/mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** TerSera Therapeutics LLC

**Marketing category:** BLA (BLA761150)

**Pharmacologic class:** HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]